Relationship between ratio SMR/THETA, simulation of symptoms and quality of life in patients with fibromialgia

Main Article Content

Carlos Barbosa Torres
Sixto Cubo Delgado
Florencio Vicente Castro

Abstract

In the present work we find a study on the relationship between the SMR / Theta ratio, the simulation of symptoms and the quality of life in patients with fibromyalgia. Fibromyalgia disease is a syndrome associated with multiple symptoms ranging from sleep problems, fatigue or chronic fatigue and alterations in cognition. The study was conducted with a sample of 40 patients with fibromyalgia under the criteria of the American Rheumatology Association. The instruments used were, the Structured Inventory of Simulation of symptoms and SF-36 Health Survey. The results show that there is a relationship between quality of life and the SMR / Theta ratio but not with the simulation of symptoms, so we can conclude that people with the lowest SMR / theta ratio have a worse score in the quality test of life.

Downloads

Download data is not yet available.

Article Details

How to Cite
Barbosa Torres, C., Cubo Delgado, S., & Vicente Castro, F. (2019). Relationship between ratio SMR/THETA, simulation of symptoms and quality of life in patients with fibromialgia. International Journal of Developmental and Educational Psychology. Revista INFAD De Psicología., 1(1), 137–142. https://doi.org/10.17060/ijodaep.2019.n1.v1.1397
Section
Articles
Author Biographies

Carlos Barbosa Torres, Universidad de Extremadura

Doctorando Universidad de Extremadura

Sixto Cubo Delgado, Universidad de Extremadura

Prof. Titular Universidad de Extremadura

Florencio Vicente Castro, Universidad de Extremadura

Catedrático Universidad Extremadura

References

Alonso, J., Priento, L. & Antó, J. M. (1995). La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): Un instrumento para la medida de los resultados clínicos. Med Clin, 104, 771-6.

American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders (DSM-IV-TR). Washington, DC: APA.

Arostegui, I. & Núñez-antón, v. (2008). Aspectos estadísticos del Cuestionario de Calidad de Vida relacionada con salud Short Form–36 (SF-36). Estadística Española, 50(167), 147-192.

Burckhardt, C. S., Clark, S. R. & Bennett, R. M. (1993). Fibromyalgia and quality of life: a comparative analysis. J Rheumatol, 20(3), 475-9.

Capilla Ramirez, Gonzalez Ordi & Santamaria (2013). Fibromialgia: ¿exageración o simulación? Clínica y Salud, 24, 185-195.

Da Costa, D., Dobkin, P. L., Fitzcharles, M. A., Fortin, P. R., Beaulieu, A., Zummer, M., et al. (2000). Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. The Journal of Rheumatology, 27, 65-72.

Egner, T., & Gruzelier, J. (2001). Learned self-regulation of EEG frequency components affects attention and event-related brain potentials in humans. Neuroreport, 12(18), 4155-4159. http://dx.doi.org/10.1097/00001756-200112210-00058

Fitzcharles, M., Shir, Y., Ablin, J., Buskila, D., Amital, H., Henningsen, P., & Häuser, W. (2013). Classification and Clinical Diagnosis of Fibromyalgia Syndrome: Recommendations of Recent Evidence-Based Interdisciplinary Guidelines. Evidence-Based Complementary And Alternative Medicine, 2013, 1-9. http://dx.doi.org/10.1155/2013/528952

Garg, N. & Deodhar, A. (2012). New and modified fibromyalgia diagnostic criteria: Ambiguity, uncertainty, and difficulties complicate diagnosis and management. J Musculoskel Med. 29, 1–5.

González Ordi, H & Santamaría, P. (2009). Adaptación española del Inventario Estructurado de Simulación de Síntomas. Madrid: TEA Ediciones.

González-Ordi, H., Santamaría, P. & Capilla, P. (2012). Estrategias de detección de la simulación. Un manual clínico multidisciplinar. Madrid: TEA Ediciones.

Jones, J., Rutledge, D., Jones, K., Matallana, L., & Rooks, D. (2008). Self-Assessed Physical Function Levels Of Women with Fibromyalgia. Women’s Health Issues, 18(5), 406-412. http://dx.doi.org/10.1016/j.whi.2008.04.005

Kropp, P. R., & Rogers, R. (1993). Understanding Malingering: Motivation, Method, and Detection. In M. Lewis, & C. Saarni, (Eds.). Lying and deception in everyday life (pp. 201- 216). Nueva York: Guilford Press.

Mease, P., Arnold, L. M., Choy, E. H., Clauw, D. J., Crofford, L. J., Glass, J. M., et al. (2009). Fibromyalgia síndrome module at OMERACT 9: domain construct. J Rheumatol.36 (10), 2318-29.

Mittenberg, W., Patton, C., Canyock, E., & Condit, D. (2002). Base Rates of Malingering and Symptom Exeggeration. Journal Of Clinical And Experimental Neuropsychology (Neuropsychology, Development And Cognition: Section A), 24(8), 1094-1102. http://dx.doi.org/10.1076/jcen.24.8.1094.8379

Queiroz, L. P. (2013). Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep,17(8), 356.

Sterman, M. (2000). Basic Concepts and Clinical Findings in the Treatment of Seizure Disorders with EEG Operant Conditioning. Clinical EEG And Neuroscience, 31(1), 45-55. http://dx.doi.org/10.1177/155005940003100111